Skip to content
  • About
  • Shop
  • News
  • Contact Us
Search
NECA Logo
  • NET Nurse
  • Donate
  • What are NETs?
    • What are Neuroendocrine Cancers?
    • What are Pheos & Paras?
    • NET Symptoms
    • NET Types
    • Causes
    • Treatments
    • Grades
    • Diagnosis
    • Prognosis
    Consider the Grey Area
  • Patients & Carers
    • Patient & Carer Support
    • Patient Resources
    • Optimal Care Pathway
    • NET Nurse
    • Patient Stories
    • Share your Story
    • Australian NET Specialists
    • Clinical Trials
    • Living with NETS
    • Specialist Support Services
    Consider the Grey Area
  • Healthcare Professionals
    • Optimal Care Pathway
    • Professional Learning
    • Patient Referral
    • Clinical Trials
    • NET Symptoms
    • Australian NET Specialists
    • Request an In-Service
    • PLANET Registry
    • Order Booklets & Resources
    Consider the Grey Area
  • Get Involved
    • Advocate for Us
    • Share your Story
    • Donate
    • Fundraise
    • Events
    • In Memoriam
    • Corporate Partners
    • Gifts & Wills
    • Volunteer
    Senate MailChimp
  • March4NETs
NET Nurse
Donate

Home » Advocacy » Australasian Association of Nuclear Medicine (AANMS) inaugural education workshop

Australasian Association of Nuclear Medicine (AANMS) inaugural education workshop

  • August 29, 2022

NECA had a great weekend at the Australasian Association of Nuclear Medicine (AANMS) inaugural Theranostics course. It was fabulous to bring Cancer Nurse Coordinators and nuclear medicine nurses from around the country together to gain knowledge in the field of Theranostics, share experiences & network ideas.

The meeting was attended by many multidisciplinary specialists, technicians and nurses with presentations about the effects of treatment in improving QOL and enabling progression free survival to many patients.  Most importantly the course provided case studies presentations by multidisciplinary panels. These were very informative as these case studies demonstrated how and why decisions about treatment are made. 

Theranostics is now a key treatment for patients with NETs who have receptor positive disease (and other cancers such as Prostate and Thyroid cancers) as it is targeted and aims to decrease the disease progression. 

The conference was also a great networking opportunity for healthcare professionals who are at the forefront of Theranostics daily. In one session the nurses heard from NET patient Carole who is currently undergoing PRRT treatment, and how this treatment has been life changing.

This conference highlighted what we what now know and enhanced all who attended knowledge base. Theranostics is the way of the future as more and more benefits and positive results are seen with its use.

The Theranostic Nurse Special Interest Group has proven to be a great forum for nurses involved in the care of NETs patients to network. This group ables discussions about the latest treatments and management of care. To have patient stories and case studies presented with robust panel discussions provided information about the latest in Theranostics treatment.

Thank you to AANMS, ANSTO & Cyclotek for your support in bringing everyone together. This course has provided valuable information for the care of patients undergoing their nuclear medicine treatments. Everyone who attended AANMS Theranostic Course 2022 is looking forward to attending next year!

Share this post

Recent posts

VHL Awareness Month 2025

May 6, 2025

NET Patient Chris, from Ballarat, Raises Awareness of Neuroendocrine Cancer

May 5, 2025

Help Us Grow: Connect NECA with Corporate Partners to Make a Lasting Impact

April 29, 2025

Neuroendocrine Cancer Awareness Daily Mail 5 April 2025

April 5, 2025
Categories
  • Advocacy
  • Awareness
  • Community Events
  • Education
  • Events
  • Fundraising
  • General
  • In The Media
  • News
  • Research
  • Unicorn Events
PrevPreviousPeter MacCallum Cancer Centre NET Centre of Excellence expands
NextCan Forum 2022Next

Related Posts

NET Patient Chris, from Ballarat, Raises Awareness of Neuroendocrine Cancer

NeuroEndocrine Cancer Australia (NECA) is proud to recognise the advocacy efforts of NET patient Chris Geljon, who has taken the time to raise awareness of

Help Us Grow: Connect NECA with Corporate Partners to Make a Lasting Impact

NeuroEndocrine Cancer Australia (NECA) is proud to be the voice for thousands of Australians living with Neuroendocrine Cancer (NETs). But to do more — reach

Parliament House representation for Federal Budget briefings

NECA attends the Treasurer’s Speech at Parliament House and then Medicines Australia Patient Organisation Brief at the Press Club on Wednesday 26 March 2025. The

VHL in the news March 2025

Read the Magazine copy here.

View All

Subscribe to Newsletter

NECA Logo
registered charity badge

What are NETs

  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies
  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies

Patients & Carers

  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library
  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library

Healthcare Professionals

  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials
  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials

Get Involved

  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
All charity donations to NeuroEndocrine Cancer Australia may be tax-deductible in Australia.

Registered Charity CFN 202607
© 2025 NeuroEndocrine Cancer Australia
  • Website by Five Creative
Twitter Facebook Youtube Instagram Linkedin